Back to Search Start Over

GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like.

Authors :
Wang S
Tsui V
Crawford TD
Audia JE
Burdick DJ
Beresini MH
Côté A
Cummings R
Duplessis M
Flynn EM
Hewitt MC
Huang HR
Jayaram H
Jiang Y
Joshi S
Murray J
Nasveschuk CG
Pardo E
Poy F
Romero FA
Tang Y
Taylor AM
Wang J
Xu Z
Zawadzke LE
Zhu X
Albrecht BK
Magnuson SR
Bellon S
Cochran AG
Source :
Journal of medicinal chemistry [J Med Chem] 2018 Oct 25; Vol. 61 (20), pp. 9301-9315. Date of Electronic Publication: 2018 Oct 05.
Publication Year :
2018

Abstract

The biological functions of the dual bromodomains of human transcription-initiation-factor TFIID subunit 1 (TAF1(1,2)) remain unknown, although TAF1 has been identified as a potential target for oncology research. Here, we describe the discovery of a potent and selective in vitro tool compound for TAF1(2), starting from a previously reported lead. A cocrystal structure of lead compound 2 bound to TAF1(2) enabled structure-based design and structure-activity-relationship studies that ultimately led to our in vitro tool compound, 27 (GNE-371). Compound 27 binds TAF1(2) with an IC <subscript>50</subscript> of 10 nM while maintaining excellent selectivity over other bromodomain-family members. Compound 27 is also active in a cellular-TAF1(2) target-engagement assay (IC <subscript>50</subscript> = 38 nM) and exhibits antiproliferative synergy with the BET inhibitor JQ1, suggesting engagement of endogenous TAF1 by 27 and further supporting the use of 27 in mechanistic and target-validation studies.

Details

Language :
English
ISSN :
1520-4804
Volume :
61
Issue :
20
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
30289257
Full Text :
https://doi.org/10.1021/acs.jmedchem.8b01225